Unveiling Physiological and Psychosocial Pain Components with an Artificial Intelligence Based Telemonitoring Tool

Launched by ETH ZURICH · Sep 13, 2023

Keywords

ClinConnect Summary

The pAIn-sense study is a clinical trial designed to improve how we understand and treat chronic pain, which can deeply affect both physical health and emotional well-being. This study is particularly focused on two types of pain: nociceptive pain (which occurs after an injury) and neuropathic pain (which is caused by nerve damage). Researchers will use advanced technology, including wearable devices and Artificial Intelligence (AI), to continuously monitor participants’ pain levels and emotional states throughout their daily activities. This will help gather detailed information about their pain experiences in real-time.

To be eligible for this study, participants should be aged between 18 and 75 years and currently experiencing ongoing pain. They should also be comfortable using electronic devices. However, individuals who have difficulty understanding the study procedures or cannot give their consent due to certain health conditions may not qualify. Participants can expect to wear a device that tracks their pain and emotional responses, which could lead to better pain management strategies in the future. This trial offers an exciting opportunity to contribute to a new approach in understanding and treating chronic pain.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Ongoing nociceptive pain after an injury or Neuropathic pain (acute or chronic)
• • Familiar with using electronic devices
• Exclusion Criteria:
• • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
• • Unable or not willing to give informed consent